Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

UN Environment Programme

- PMLiVE

World Health Organization publishes updated essential medicines list

Three medicines that can delay or slow MS disease progression have been included in the EML

- PMLiVE

NHS launches plans to expand drug contracts to develop new life-saving antibiotics

New antibiotics could reduce death rates and ensure future pandemic preparedness

- PMLiVE

Shionogi to acquire Qpex Biopharma for approximately $140m

The deal signifies a notable expansion to the Japanese drugmaker’s antimicrobial pipeline

- PMLiVE

International Respiratory Coalition urges policymakers to help lift disease burden

The societal and economic cost of respiratory disease in Europe is reportedly over €600bn

- PMLiVE

World Health Organization publishes research agenda for antimicrobial resistance

AMR has been declared by WHO as one of the top ten threats to global public health

- PMLiVE

Pfizer’s antibiotic combination shows promise in treating multi-drug resistant infections

AMR has been declared by WHO as one of the top ten threats to global health

- PMLiVE

WHO report shows progress as well as gaps in AMR antibiotic pipeline

AMR has been declared as one of the top ten global public health threats by the organisation

- PMLiVE

WHO declares end to COVID-19 global public health emergency

The agency’s emergency committee said it is time to transition to long-term management of the pandemic

- PMLiVE

WHO announces launch of new pandemic preparedness initiative

The guidance focuses on respiratory pathogens, including influenza and RSV

- PMLiVE

WHO and global partners launch new effort to address falling childhood vaccination rates

Over 25 million children missed at least one vaccination in 2021 alone

- PMLiVE

WHO releases largest global collection of publicly available health inequality data

The repository is composed of nearly 11 million data points across more than 2,000 indicators

- PMLiVE

Shionogi’s cefiderocol shows efficacy against difficult-to-treat bacterial infections

Antimicrobial resistance has been declared as one of the top ten threats to global health

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links